6908 studies found for:    "Growth Substances"
Show Display Options
Download search resultsDownload the search results for:
"Growth Substances" (6908 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Conditions: Metastatic Hepatocellular Carcinoma;   Advanced Liver Cancer
Interventions: Drug: Ascorbic Acid + Sorafenib;   Drug: Sorafenib alone
2 Active, not recruiting Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
3 Terminated Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Condition: Stage IV Colorectal Cancer
Intervention: Drug: Vitamin C
4 Terminated Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors
Conditions: Neuroendocrine Tumors;   Pancreatic Neoplasms;   Advanced Disease;   Sunitinib
Intervention: Drug: Sutent
5 Terminated Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma
Conditions: Hepatocellular Carcinoma;   Fibrolamellar Hepatocellular Carcinoma
Intervention: Drug: Sutent
6 Completed Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu)
Conditions: Respiratory Tract Infections;   Influenza
Interventions: Dietary Supplement: Cholecalciferol (Vitamin D/Vigantol oil);   Dietary Supplement: Miglyol oil
7 Terminated Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Non-resectable;   Hepatocellular Carcinoma Recurrent;   Carcinoma, Hepatocellular;   Liver Diseases;   Neoplasms by Histologic Type;   Digestive System Neoplasms;   Carcinoma;   Liver Neoplasms;   Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Adenocarcinoma;   Neoplasms, Glandular and Epithelial
Interventions: Drug: ABT-869;   Drug: Sorafenib
8 Completed Patellar Tendon Regeneration With Platelet-rich Plasma
Condition: Knee Instability
Interventions: Procedure: Platelet-rich plasma;   Procedure: Control group
9 Terminated Growth Hormone and Heart Failure
Condition: Heart Failure, Congestive
10 Completed A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy
Conditions: HIV Infections;   Peripheral Nervous System Disease
Intervention: Drug: Nerve Growth Factor, Recombinant Human
11 Completed Impact of Vitamin D Supplementation on Recurrent Respiratory Infections in Paediatric Primary Care.
Condition: Recurrent Respiratory Tract Infections
Intervention: Drug: Vitamin D3
12 Not yet recruiting A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Durvalumab;   Drug: Pomalidomide;   Drug: Dexamethasone
13 Completed Dietary Intake of Salmon and Bone Health
Condition: Osteoporosis
Interventions: Dietary Supplement: Tailor-made salmon with high levels of vitamin D3 and K1;   Dietary Supplement: Tailor-made salmon with low levels of vitamin D3 and high K1;   Dietary Supplement: Tailor-made salmon with high levels of vitamin D3 and low K1;   Dietary Supplement: Supplement with vitamin D and Calcium
14 Completed High Dose Vitamin D3 in Crohn's Disease
Condition: Crohn's Disease
Intervention: Dietary Supplement: Vitamin D3
15 Recruiting Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Endostar;   Radiation: 21.6Gy/12Fx to the tumor bed and 36Gy/20Fx to the tumor
16 Completed Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion
Conditions: Retinal Vein Occlusion;   Macular Edema
Interventions: Drug: ranibizumab;   Drug: Squalamine Lactate Ophthalmic Solution, 0.2%
17 Not yet recruiting Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis
Condition: Vitamin D Deficiency
Intervention: Drug: Treatment
18 Recruiting Evaluation of Lipoic Acid as a Treatment for Geographic Atrophy
Condition: Age-Related Macular Degeneration
Intervention: Drug: alpha lipoic acid
19 Recruiting Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration
Condition: Neovascular Age-related Macular Degeneration
Intervention: Biological: TK001
20 Recruiting A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Patients With Metastatic Her 2- Negative and Aggressive Disease Criteria
Condition: Metastatic Breast Cancer
Interventions: Drug: Bevacizumab;   Drug: Paclitaxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years